Induction chemotherapy regimen of docetaxel plus cisplatin versus docetaxel, cisplatin plus fluorouracil followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Preliminary results of an open-label, noninferiority, multicentre, randomised, controlled phase 3 trial

Summary: Background: Induction chemotherapy regimens of docetaxel and cisplatin plus fluorouracil (TPF) are currently clinically used for patients with locoregionally advanced nasopharyngeal carcinoma (LA-NPC) but have well-known side effects, such as myelosuppression and diarrhea. A docetaxel plus...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yan Wang, Chengtao Wang, Shasha He, Li Bai, Fei Kong, Siyang Wang, Lei Cui, Qiang Qin, Yunying Yang, Wei Xiao, Meiyan Zhu, Zeyu Zhang, Yulin Lai, Wenjing Bao, Zhenwei Peng, Yong Chen
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2022-11-01
coleção:	EClinicalMedicine
Assuntos:	Nasopharyngeal carcinoma Docetaxel plus cisplatin (TP) Docetaxel, cisplatin plus fluorouracil (TPF) Survival Toxicity
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2589537022003558
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!